Skip to content

Inspiratory Muscle Training in Patients With Chronic Heart Failure

The INCA Study: Inspiratory Muscle Training in Patients With Chronic Heart Failure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01606553
Acronym
INCA
Enrollment
22
Registered
2012-05-25
Start date
2010-10-31
Completion date
2012-06-30
Last updated
2016-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure

Keywords

chronic heart failure, respiratory muscle weakness, inspiratory muscle training

Brief summary

The purpose of this study is to determine whether a high intensity short duration inspiratory muscle training is feasible, secure and effective to improve respiratory muscle function (strength and resistance), health-related quality of life, and to assess potential correlations with health resources utilization.

Detailed description

Patients with chronic heart failure (CHF) often refer exercise intolerance, marked fatigue and dyspnea at low exercise intensities. This characteristic feature might be generated by respiratory and skeletal muscle dysfunction, and it´s has been described as a comorbid status, reflecting the systemic impact of heart failure. Despite the availability of effective pharmacologic treatments, patients with CHF continue to experience progressively worsening symptoms, frequent hospital admission and premature death. Reduced physical functioning, role limitation, and lack of energy may interfere with daily activities as the condition worsens and thereby severely reduce the quality of life in CHF patients. The ACCF/AHA Guidelines for the diagnosis and management of heart failure recommend exercise training as an adjunctive approach to improve clinical status in stable adult patients with current or prior symptoms of heart failure and reduced left ventricular ejection fraction. A wide variety of studies have focussed on respiratory muscles abnormalities in CHF patients. Reduced strength and endurance of respiratory muscles are currently recognized as additional factors implicated in the limited exercise response and quality of life, as well as in a poor prognosis. Additionally, inspiratory muscle training (IMT) has shown to result in improvements on inspiratory strength, functional capacity, ventilatory response to exercise, recovery oxygen uptake kinetics, and quality of life of CHF patients with respiratory muscle weakness. The optimal training scheme remains still to be defined. Most of clinical trials have demonstrated the effectiveness of a low-intensity IMT (maximum 38 cmH2O), but there is little information of the training effects when using higher training loads. Our research group has demonstrated that a short-time high-intensity respiratory training in patients with chronic obstructive pulmonary disease afford to reach good functional results in a shorter time, which affords to make more efficient in terms of time the rehabilitation program and to reach to more patients.

Interventions

High intensity short duration respiratory muscle training with a valve prototype

DEVICESham High-intensity IMT

High intensity short duration respiratory muscle training using a sham valve prototype

Sponsors

Parc de Salut Mar
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. age over 18 years; 2. chronic heart failure (CHF) of any etiology; 3. clinically stable condition, with no worsening of heart failure or change in cardiac medication in the previous 3 months and during the study; and 4. ability to understand and accept the trial procedures and to sign an informed consent form in accordance with national legislation.

Exclusion criteria

1. previous history of any chronic respiratory disease; 2. not to have performed any kind of general or respiratory training in the previous 3 months. * Prior to randomization, all patients' clinical assessment and echocardiographic measurements were done by a cardiologist and all patients underwent pulmonary function tests.

Design outcomes

Primary

MeasureTime frameDescription
Change in respiratory muscle function strengthBaseline to 4 weeksTransducer measuring maximal inspiratory and expiratory pressures

Secondary

MeasureTime frameDescription
Change in health-related quality of lifeBaseline to 4 weeksMinnesotta Living wih Heart Failure Questionnaire and Short Form 36
Adverse effects from trainingBaseline to week 4Adverse events collection by investigator
Health care utilizationBaseline to one yearHospital admissions and emergency room visits

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026